Company Profile
Kernal Biologics, Inc.
Company Overview
Kernal Bio is a VC-backed Biotech company that is creating mRNA drugs that instruct specific cells in the body on how to make their own medicine. Messenger RNA technology has proven extremely useful in rapidly developing vaccines against COVID-19. Kernal Bio is developing the next-generation of mRNA therapy, called mRNA 2.0. It solves a critical problem of cell selectivity that affects many therapeutic candidates. Cell specific mRNAs are formulated with proprietary, best-in-class LNPs validated in non-human primates (NHPs).
Based in Cambridge, MA, the company is backed by Hummingbird Ventures, Amgen Ventures, HBM Partners, NASA, and Boeing. With roots at MIT, Harvard, and biopharma industry, Kernal Bio’s interdisciplinary team of MDs and PhDs previously built a successful Biotech company and has deep expertise in nucleic acid-based therapeutics and immuno-oncology space.
Benefits
• Competitive 401(k)
• Highly competitive healthcare coverage
• On-site subsidized cafeteria
• Free MIT Athletic Membership
• Free Bluebikes Membership
• Flexible Spending Account
• Paid parental leave, family caregiver leave, medical leave
• Paid insurance coverage
• Competitive vacation and sick days per year